131 related articles for article (PubMed ID: 15160285)
21. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
22. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
23. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.
Rinaldi S; Sesto A; Barsotti P; Faraggiana T; Sera F; Rizzoni G
Pediatr Nephrol; 2005 Jan; 20(1):25-9. PubMed ID: 15602664
[TBL] [Abstract][Full Text] [Related]
25. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
Matsumoto H; Nakao T; Okada T; Nagaoka Y; Shino T; Yoshino M; Hidaka H
Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
[TBL] [Abstract][Full Text] [Related]
26. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[TBL] [Abstract][Full Text] [Related]
29. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M; Ishihara M; Morita T; Hayashi A; Okada S; Ohta T; Sakano T; Wakiguchi H
Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
[TBL] [Abstract][Full Text] [Related]
30. Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low dose ciclosporine-A for 2 years for steroid-dependent nephrotic syndrome.
Kano K; Kyo K; Yamada Y; Ito S; Ando T; Arisaka O
Clin Nephrol; 1999 Jul; 52(1):19-24. PubMed ID: 10442491
[TBL] [Abstract][Full Text] [Related]
31. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
Fujinaga S; Ohtomo Y; Umino D; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
[TBL] [Abstract][Full Text] [Related]
32. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
Fujinaga S; Hirano D; Nishizaki N; Someya T; Ohtomo Y; Ohtsuka Y; Shimizu T; Kaneko K
Pediatr Nephrol; 2011 Mar; 26(3):479-83. PubMed ID: 21174219
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B; Ossman MI; Sheriff S
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporin therapy in steroid-dependent nephrotic syndrome.
Webb KL; Sargent P; Burke JR
J Paediatr Child Health; 1993 Jun; 29(3):188-91. PubMed ID: 8518000
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity.
Kano K; Yamada Y; Shiraiwa T; Shimizu A; Nishikura K; Arisaka O; Tomita S; Ueda Y
Nephrology (Carlton); 2004 Dec; 9(6):414-7. PubMed ID: 15663646
[TBL] [Abstract][Full Text] [Related]
36. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
Cao Q; Huang WY; Xu H; Zhou LJ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):698-701. PubMed ID: 19099862
[TBL] [Abstract][Full Text] [Related]
37. Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome.
Ingulli E; Tejani A
J Am Soc Nephrol; 1992 Aug; 3(2):254-9. PubMed ID: 1391723
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
[TBL] [Abstract][Full Text] [Related]
39. Single daily dose of cyclosporine in patients with primary glomerulonephritis and nephrotic syndrome.
Rasche FM; Keller F; Kunze G; Boesler B; Czock D
Clin Nephrol; 2007 May; 67(5):285-92. PubMed ID: 17542337
[TBL] [Abstract][Full Text] [Related]
40. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N; Kim S; Craig J; Hodson E
Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
